Star Equity Holdings, Inc.

Greetings ladies and gentlemen and welcome to Star Equity Holdings third quarter 2022 results conference call. Please be advised that the discussions on today's call may include forward-looking statements. Such forward-looking statements involve certain risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. Please refer to Star Equity's most recent PEN-K and PEN-Q filings and also third quarter PEN-Q. which we expect to file on Monday, November 14, 2022, for a more complete description of risk factors that could affect these projections and assumptions. The company assumes no obligation to update forward-looking statements as a result of new information, future events, or otherwise. Please also note that on this call, management will reference non-GAAP financial measures, including EBITDA, adjusted EBITDA, adjusted net income, and adjusted earnings per share. which are all financial measures not recognized under U.S. GAAP. As required by SEC rules and regulations, these non-GAAP financial measures are reconciled to the most comparable GAAP financial measures in our earnings release issued this morning. If you did not receive a copy of the earnings release and would like one after the call, please contact Star Equity at 203-489-9500 or its investor relations representative, Lena Cotty, of the Equity Group at 212-836-9611. Also, this call is being broadcast live over the internet and may be accessed at Star Equity's website via www.starequity.com. Shortly after the call, our replay will also be available on the company's website. It is now my pleasure to introduce Rick Coleman, Chief Executive Officer of Star Equity. Please go ahead, sir.

Thank you, Maria. Good morning, and thanks for joining us today for our third quarter 2022 results conference call. On the call with me today are Executive Chairman Jeff Everwine and Chief Financial Officer Dave Noble. I'm pleased to report significant progress in both our construction and healthcare businesses this quarter. On a consolidated basis, despite an overall 16% decrease in revenue, we grew gross profit by 54.8% versus the third quarter of last year. Growth profit was driven predominantly by substantially increased profitability at our construction division and strong operating discipline in our healthcare division. Our healthcare division revenue decreased by 11.3% compared to the third quarter of last year, and growth margin decreased by one percentage point to 20.7%. Both results were primarily impacted by the continued effect of labor market tightness on our scanning service utilization. Late in the quarter, we began to see modest improvement in the availability of nuclear medicine technologist applicants, which we're hopeful will continue to provide staffing relief and allow more patient study hours. Despite the labor-driven reduction in activity, our healthcare division delivered a million dollars of adjusted EBITDA in the quarter due to strong cost controls and organizational improvements from our second quarter restructuring. Our construction division revenue decreased by 21%. due primarily to the timing of revenue recognition on certain projects, which had a positive impact in the prior quarter. Specifically, contract terms and accelerated performance allowed a higher percentage of revenue for a large New England college project to be recognized in the second quarter for a project that was successfully completed in August. Similar to last quarter, gross margin improved substantially to 28.2%, due to increased pricing, improved operations, and commodity price risk mitigation. Despite quarterly variations due to the timing of profit recognition, particularly on large projects, we expect our construction division to continue performing over time against our 20% gross margin target. Our Q3 results indicate that our geographic and industrial diversification strategy is playing out as expected and showing balanced results. In Q3, our construction segment accounted for 45.8% of Star Equity's consolidated revenue. And for the first nine months of 2022, our construction segment accounted for 49.4% of total revenue. Finally, we continue to be optimistic about the overall performance of our operating portfolio and about our ability to identify and integrate future acquisitions, either as bolt-ons for existing divisions or entry into a new business sector. Now I'll turn the call over to our CFO, Dave Noble, to provide more detail on our operating results and provide additional third quarter financial highlights.

Dave, please go ahead. Thank you, Rick, and good morning. Let me first address the strong underlying performance of the healthcare division. As Rick mentioned, revenue was a bit softer due to external conditions in the labor market. While gross margin was 20.7% in Q3 versus 22.0% in Q3 of 2021, year-to-date gross margin is higher than the prior nine-month period at 23.7%. Excluding the legal costs mostly for a single large case, non-GAAP adjusted EBITDA for healthcare was $1.0 million in Q3 versus $1.3 million in Q3 of 2021. For the first nine months of 2022, non-GAAP adjusted EBITDA for healthcare was $3.9 million versus $3.0 million in the first nine months of 2021. These numbers are segment level numbers before allocating any public company expenses. Let me next touch on the strong turnaround performance of our construction division. Q3 construction revenue was $11.1 million versus $14.1 million in Q3 of 2021. The 21% year-over-year quarterly decrease relates to the timing of revenue recognition for a large KVS project, as Rick mentioned. Additionally, we experienced some project delays at our edge builder business, but fully expect those projects to have a positive fourth quarter impact. Our year-to-date results and Q4 outlook remain quite strong. For the first nine months of 2022, construction revenues were $39.5 million versus $34.0 million in the first nine months of 2021. This represents a 16.2% growth in revenues year-to-date. Construction gross margin was 28.2% for a gross profit of $3.1 million in Q3 versus just 3.8% or $0.5 million in the prior year Q3. For the first nine months of 2022, construction gross margin was 18.2% or $7.2 million versus a negative 2.2% or negative $0.8 million in the first nine months of 2021. The significant increases in gross margin percentages were due to the increased pricing levels on both residential and commercial projects, as well as a better risk management around building materials price volatility. Our construction backlog and sales pipeline both remain strong. Let us now turn to Star Equity's consolidated results. In Q3 2022, SG&A increased by 31.9% versus Q3 2021. The increase was driven primarily by the $1.2 million in one-time litigation costs, and secondarily by $0.3 million in severance and retention-related expenses associated with restructuring at Digirad Health. At the bottom line, Star Equity had a net loss from continuing operations of $1.9 million in Q3, compared to a net loss from continuing operations of 2.1 million in Q3 of 2021. Non-GAAP adjusted net income from continuing operations was a positive 0.8 million in Q3. This compares very favorably to the adjusted net loss of 1.5 million in Q3 of 2021. Non-GAAP adjusted EBITDA was 1.5 million in Q3 compared to a negative 0.6 million in Q3 of 2021. For the first nine months of 2022, adjusted EBITDA was 2.9 million versus a negative 4.5 million in the first nine months of 2021. This substantial improvement in non-GAAP adjusted EBITDA was driven by a successful operational turnaround in our construction division where segment non-GAAP adjusted EBITDA swung from a negative 3.9 million in the first nine months of 2021 to a positive 3.5 million in the first nine months of 2022. These numbers are before allocating any public company expenses. At a consolidated level, net cash used by operating activities in the first nine months of 2022 was $0.2 million versus net cash used of $8.2 million in the first nine months of 2021. As of September 30, 2022, our balance sheet and liquidity remained strong. The combined outstanding balances on our interest-bearing credit facilities was $11.9 million. while cash and cash equivalents on our balance sheet stood at 8.5 million. Now I'll turn the call back to Rick for some additional comments.